Active Surveillance Methodology for Low Risk Prostate Cancer
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
An active surveillance protocol for patients diagnosed low-risk prostate cancer will be held. We plan to use PSA (prostate-specific antigen) testing, DRE (digital rectal examination), TRUS (transrectal ultrasound), MRI (magnetic resonance imaging) and follow-up biopsies to monitor patients and detect cancer progression in time.
Eligibility
Participation Requirements
Sex: Male
Minimum Age: 50
Maximum Age: 75
Healthy Volunteers: f
View:
• prostate adenocarcinoma verified by at least 12 core biopsy
• patient must understand the sense of research, agree to participate and sign a form of agreement
• low oncological risk according to EAU (European Association of Urology) Guidelines: stage T1-T2a, PSA\<10 ng/ml, ISUP (International Society of Urological Pathologists score)=1 (Gleason score 3+3=6)
• not more than 33% cores with adenocarcinoma
Locations
Other Locations
Russian Federation
Institute for Urology and Reproductive Health, Sechenov University.
RECRUITING
Moscow
Time Frame
Start Date: 2019-10-01
Estimated Completion Date: 2026-10
Participants
Target number of participants: 100
Related Therapeutic Areas
Sponsors
Collaborators: Pirogov Russian National Research Medical University, Moscow Regional Research and Clinical Institute (MONIKI)
Leads: I.M. Sechenov First Moscow State Medical University